首页> 外文期刊>Clinical & translational oncology : >The incidence proportion of erectile dysfunction in patients treated with cryotherapy for prostate cancer: a meta-analysis
【24h】

The incidence proportion of erectile dysfunction in patients treated with cryotherapy for prostate cancer: a meta-analysis

机译:前列腺癌冷冻治疗患者勃起功能障碍的发病率比例:荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectivesWith the maturity of cryotherapy for prostate cancer, the complications after operation are also decreasing, which can improve the prognosis of patients. However, erectile dysfunction (ED) is still one of the main complications after cryotherapy. Therefore, we performed a meta-analysis to evaluate the incidence of erectile dysfunction in patients after cryotherapy.Materials and methodsA comprehensive literature search was performed in August 2018. PUBMED and EMBASE databases were searched to collect studies reporting the incidence rate of ED after cryotherapy from 2002 to 2018. Two reviewers independently screened the literatures, extracted data and assessed the risk of bias of included studies. Pooled ratio and its 95% confidence intervals (95% CIs) were performed by Stata 12.1.ResultsOf the 157 articles identified on August 1st 2018, 23 studies which reported ED after cold ablative therapy were identified, however, only 12 used validated outcome measures and met inclusion criteria. A total of 12 studies were included in this meta-analysis. Overall, the results of this meta-analysis showed that the pooled incidence rate of ED was 0.27 (95% CI 0.26-0.28) which means that the incidence rate of ED after cryotherapy for prostate cancer was not high, but we still found that there are great heterogeneity between the 12 articles. By subgroup analysis, we found a statistically significant incidence rate of ED in primarily localized PCa which was 0.49 (95% CI 0.30-0.68), which is clearly lower than the incidence of recurrent prostate cancer after failed primary radiotherapy 0.61 (95% CI 0.43-0.79).ConclusionED is one of the major complications after cryotherapy for PCa. Furthermore, subgroup analysis revealed a higher incidence rate in PCa undergoing radiotherapy. Significantly, with the development of cryotherapy technology, the incidence of ED after cryotherapy for prostate cancer is decreasing. While we still need further researches to advance knowledge in this field.
机译:对象在前列腺癌的冷冻疗法成熟时,手术后的并发症也在降低,这可以改善患者的预后。然而,勃起功能障碍(ED)仍然是冷冻疗法后主要并发症之一。因此,我们进行了META分析,以评估冷冻疗法后患者勃起功能障碍的发生率。关于2018年8月的材料和方法。搜索了PUBMED和EMBASE数据库,以收集报告CREY治疗后ED发病率的研究2002年至2018年。两位审稿人独立筛选了文献,提取了数据并评估了包括研究偏见的风险。汇总比率及其95%置信区间(95%CIS)由Stata 12.1进行.12.1。鉴定了157年8月1日鉴定的157篇文章,鉴定了冷冻疗法后举报的23项研究,然而,只有12种验证的结果措施符合纳入标准。该荟萃分析中共有12项研究。总的来说,该荟萃分析的结果表明,ED的汇集发生率为0.27(95%CI 0.26-0.28),这意味着前列腺癌冷冻疗法后ED的发生率并不高,但我们仍然发现在12篇文章之间存在很大的异质性。通过亚组分析,我们发现了主要局部PCA的统计学显着的发病率,该PCA是0.49(95%CI 0.30-0.68),其明显低于原发性放疗失败后的复发前列腺癌的发生率0.61(95%CI 0.43 -0.79)。Corlusioned是PCA冷冻疗法后的主要并发症之一。此外,亚组分析显示出在放射治疗的PCA中发病率较高。显着,随着冷冻疗法的发展,前列腺癌冷冻治疗后ED的发病率降低。虽然我们仍然需要进一步的研究来推进该领域的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号